T. Caraceni

2.3k total citations
90 papers, 1.8k citations indexed

About

T. Caraceni is a scholar working on Neurology, Cellular and Molecular Neuroscience and Psychiatry and Mental health. According to data from OpenAlex, T. Caraceni has authored 90 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 64 papers in Neurology, 29 papers in Cellular and Molecular Neuroscience and 11 papers in Psychiatry and Mental health. Recurrent topics in T. Caraceni's work include Neurological disorders and treatments (42 papers), Parkinson's Disease Mechanisms and Treatments (35 papers) and Genetic Neurodegenerative Diseases (21 papers). T. Caraceni is often cited by papers focused on Neurological disorders and treatments (42 papers), Parkinson's Disease Mechanisms and Treatments (35 papers) and Genetic Neurodegenerative Diseases (21 papers). T. Caraceni collaborates with scholars based in Italy, United States and Germany. T. Caraceni's co-authors include F. Girotti, Paola Soliveri, P. Giovannini, F. Carella, G. Scigliano, Massimo Musicco, D. Testa, Eugenio Parati, G. Avanzini and V. Fetoni and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Neurology and Journal of Neurology Neurosurgery & Psychiatry.

In The Last Decade

T. Caraceni

88 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
T. Caraceni Italy 26 1.3k 714 283 217 188 90 1.8k
Heidi Cartwright Australia 15 976 0.7× 659 0.9× 207 0.7× 264 1.2× 249 1.3× 17 1.5k
Gurutz Linazasoro Spain 21 1.2k 0.9× 637 0.9× 345 1.2× 165 0.8× 189 1.0× 72 1.7k
Christopher Kenney United States 21 1.3k 1.0× 749 1.0× 275 1.0× 187 0.9× 178 0.9× 32 2.0k
L J Findley United Kingdom 25 1.6k 1.2× 868 1.2× 72 0.3× 206 0.9× 118 0.6× 50 2.0k
B. V. Manyam United States 11 682 0.5× 758 1.1× 471 1.7× 233 1.1× 286 1.5× 14 1.5k
F. Girotti Italy 32 2.1k 1.6× 1.2k 1.7× 497 1.8× 470 2.2× 446 2.4× 114 2.9k
C A Bloxham United Kingdom 17 615 0.5× 346 0.5× 221 0.8× 450 2.1× 164 0.9× 33 1.6k
E. Tolosa Spain 23 1.3k 1.0× 594 0.8× 205 0.7× 394 1.8× 240 1.3× 46 1.8k
Cliff Shults United States 11 996 0.8× 410 0.6× 180 0.6× 210 1.0× 235 1.3× 12 1.4k
Chin‐Song Lu Taiwan 26 1.1k 0.8× 650 0.9× 208 0.7× 321 1.5× 600 3.2× 61 2.0k

Countries citing papers authored by T. Caraceni

Since Specialization
Citations

This map shows the geographic impact of T. Caraceni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T. Caraceni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T. Caraceni more than expected).

Fields of papers citing papers by T. Caraceni

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by T. Caraceni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T. Caraceni. The network helps show where T. Caraceni may publish in the future.

Co-authorship network of co-authors of T. Caraceni

This figure shows the co-authorship network connecting the top 25 collaborators of T. Caraceni. A scholar is included among the top collaborators of T. Caraceni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with T. Caraceni. T. Caraceni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Stocchi, Fabrizio, Luca Barbato, Giampietro Nordera, Andrea Bolner, & T. Caraceni. (2004). Entacapone improves the pharmacokinetic and therapeutic response of controlled release levodopa/carbidopa in Parkinson?s patients. Journal of Neural Transmission. 111(2). 173–180. 17 indexed citations
2.
Lucignani, Giovanni, C. Gobbo, Rosa Maria Moresco, et al.. (2002). The feasibility of statistical parametric mapping for the analysis of positron emission tomography studies using 11C-2-β-carbomethoxy-3-β-(4-fluorophenyl)-tropane in patients with movement disorders. Nuclear Medicine Communications. 23(11). 1047–1055. 16 indexed citations
3.
Caraceni, T. & Massimo Musicco. (2001). Levodopa or dopamine agonists, or deprenyl as initial treatment for Parkinson's disease. A randomized multicenter study. Parkinsonism & Related Disorders. 7(2). 107–114. 20 indexed citations
4.
Sterzi, Roberto, et al.. (1999). Sporadic Choreas: Analysis of a General Hospital Series. European Neurology. 41(3). 143–149. 5 indexed citations
5.
Monza, D., Paola Soliveri, Davide Radice, et al.. (1998). Cognitive Dysfunction and Impaired Organization of Complex Motility in Degenerative Parkinsonian Syndromes. Archives of Neurology. 55(3). 372–372. 47 indexed citations
6.
Fetoni, V., S. Genitrini, D. Monza, et al.. (1997). Variations in Axial, Proximal, and Distal Motor Response to L-Dopa in Multisystem Atrophy and Parkinsonʼs Disease. Clinical Neuropharmacology. 20(3). 239–244. 11 indexed citations
7.
Testa, D., et al.. (1996). Survival in multiple system atrophy: a study of prognostic factors in 59 cases. Journal of Neurology. 243(5). 401–404. 38 indexed citations
8.
Fetoni, V., et al.. (1996). Cabergoline in Parkinson's disease complicated by motor fluctuations. Movement Disorders. 11(5). 495–500. 21 indexed citations
9.
Pezzoli, Gianni, E. Martignoni, Claudio Pacchetti, et al.. (1995). A crossover, controlled study comparing pergolide with bromocriptine as an adjunct to levodopa for the treatment of Parkinson's disease. Neurology. 45(3_suppl_3). S22–7. 31 indexed citations
10.
Defazio, Giovanni, Vito Lepore, Giovanni Abbruzzese, et al.. (1994). Reliability among neurologists in the severity assessment of blepharospasm and oromandibular dystonia: A multicenter study. Movement Disorders. 9(6). 616–621. 13 indexed citations
11.
Pezzoli, Gianni, E. Martignoni, Claudio Pacchetti, et al.. (1994). Pergolide compared with bromocriptine in Parkinson's disease: A multicenter, crossover, controlled study. Movement Disorders. 9(4). 431–436. 69 indexed citations
12.
Parati, Eugenio, V. Fetoni, Giuliano Geminiani, et al.. (1993). Response to L-DOPA in Multiple System Atrophy. Clinical Neuropharmacology. 16(2). 139–144. 56 indexed citations
13.
Oliva, D., F. Carella, M. Savoiardo, et al.. (1993). Clinical and Magnetic Resonance Features of the Classic and Akinetic-Rigid Variants of Huntington's Disease. Archives of Neurology. 50(1). 17–19. 28 indexed citations
14.
Berardelli, Alfredo, A. Formica, B. Mercuri, et al.. (1993). Botulinum toxin treatment in patients with focal dystonia and hemifacial spasm. A multicenter study of the Italian Movement Disorder Group. The Italian Journal of Neurological Sciences. 14(5). 361–367. 23 indexed citations
15.
Lamperti, E., Daniela Cocchi, Eugenio Parati, T. Caraceni, & E. E. Müller. (1992). Growth Hormone Responses to Cholinergically Active Drugs in Patients with Dementia of the Alzheimer Type. Alzheimer Disease & Associated Disorders. 6(1). 44–52. 7 indexed citations
16.
Giovannini, P., S. Genitrini, Paola Soliveri, et al.. (1991). Early‐onset Parkinson's disease. Movement Disorders. 6(1). 36–42. 42 indexed citations
17.
Geminiani, Giuliano, Bruno Mario Cesana, Filippo Tamma, et al.. (1991). Interobserver reliability between neurologists in training of Parkinson's disease rating scales. A multicenter study. Movement Disorders. 6(4). 330–335. 43 indexed citations
18.
Testa, D., T. Caraceni, & V. Fetoni. (1989). Branched-chain amino acids in the treatment of amyotrophic lateral sclerosis. Journal of Neurology. 236(8). 445–447. 43 indexed citations
19.
Giovannini, P., et al.. (1988). Lisuride in Parkinsonʼs Disease. Clinical Neuropharmacology. 11(3). 201–211. 4 indexed citations
20.
Caraceni, T., F. Girotti, P. Giovannini, Massimo Pederzoli, & Eugenio Parati. (1979). Effects of DA agonist in Huntington disease hyperkinesia. Neurological Sciences. 1(2). 155–161. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Heidi Cartwright Breakdown of academic impact, for papers by Gurutz Linazasoro Breakdown of academic impact, for papers by Christopher Kenney Breakdown of academic impact, for papers by L J Findley Breakdown of academic impact, for papers by B. V. Manyam Breakdown of academic impact, for papers by F. Girotti Breakdown of academic impact, for papers by C A Bloxham Breakdown of academic impact, for papers by E. Tolosa Breakdown of academic impact, for papers by Cliff Shults Breakdown of academic impact, for papers by Chin‐Song Lu
Rankless by CCL
2026